JBI CME Volume 4, Issue 4 Educational Review

Title of Activity: JBI CME Volume 4, Issue 4 Educational Review

Article: Shedding Light on T2 Bright Masses on Breast MRI: Benign and Malignant Causes

Author: Carolynn DeBenedectis, MD

Learning Objectives:

1. Distinguish between benign and malignant T2 bright masses on MRI.
2. Identify if a T2 bright mass contains any suspicious features and characterize it as potentially malignant.

Date(s) of Activity: CE Release Date: September 1, 2022 – CE Expiration Date: September 1, 2025

Physician Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The American College of Radiology and the Society of Breast Imaging. The American College of Radiology is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation Statement: The American College of Radiology designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit: In order to successfully complete the activity, participants must complete the post-test with a passing score of 80% or higher. A maximum of 3 attempts will be allowed. Upon successful completion of the post-test, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.

Contact Information: For information about the accreditation of this program, please contact SBI at info@sbi-online.org.

Disclosure of Relevant Financial Relationships

The ACR Disclosure Policy: The American College of Radiology (ACR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ACR are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ACR in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ACR to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ACR.

The following planners and managers have no relevant financial relationships to disclose:

Ana Lourenco, MD, FSBI; Natalie Ward; Alexis LaCount

The planners, managers, and authors have the following identified relevant financial relationships:

Jennifer Harvey, MD, FSBI: Volpara, LLC, Shareholder; BHR Pharmaceuticals, Consulting Fee

The following author has no relevant financial relationships to disclose:

Carolynn DeBenedectis, MD